Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (241-250 of 336) with videos related to

Pageof 34
Sort By:
Psychoneuroendocrinology|July 23, 2016
Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemiaLidewij T Warris, Erica L T van den Akker, Femke K Aarsen, et al.
Pharmacogenetics and Genomics|June 20, 2017
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemiaAngela Gutierrez-Camino, Natanja Oosterom, Marissa A H den Hoed, et al.
Biomedicines|March 25, 2022
High-Throughput Drug Library Screening in Primary <i>KMT2A</i>-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 SignalingPriscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken, et al.
Blood|April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup studyJasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
Molecular Cancer Therapeutics|May 12, 2018
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4<sup>+</sup> Infant ALLMichela Bardini, Luca Trentin, Francesca Rizzo, et al.
Nature Genetics|April 17, 2007
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaIdoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 28, 2022
The results of concentration of care: Surgical outcomes of neuroblastoma in the NetherlandsAlida F W van der Steeg, Merel Jans, Godelieve Tytgat, et al.
British Journal of Haematology|June 1, 2021
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment responseSebastiaan D T Sassen, Ron A A Mathôt, Rob Pieters, et al.
JCO Precision Oncology|June 21, 2023
Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?Annelienke M van Hulst, Martha A Grootenhuis, Emma J Verwaaijen, et al.
The Lancet. Haematology|December 4, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trialAndrea Biondi, Virginie Gandemer, Paola De Lorenzo, et al.
Pageof 34

Showing results (241-250 of 336) with videos related to

Sort By:
Pageof 34
Psychoneuroendocrinology|July 23, 2016
Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemiaLidewij T Warris, Erica L T van den Akker, Femke K Aarsen, et al.
Pharmacogenetics and Genomics|June 20, 2017
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemiaAngela Gutierrez-Camino, Natanja Oosterom, Marissa A H den Hoed, et al.
Biomedicines|March 25, 2022
High-Throughput Drug Library Screening in Primary <i>KMT2A</i>-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 SignalingPriscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken, et al.
Blood|April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup studyJasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
Molecular Cancer Therapeutics|May 12, 2018
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4<sup>+</sup> Infant ALLMichela Bardini, Luca Trentin, Francesca Rizzo, et al.
Nature Genetics|April 17, 2007
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaIdoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 28, 2022
The results of concentration of care: Surgical outcomes of neuroblastoma in the NetherlandsAlida F W van der Steeg, Merel Jans, Godelieve Tytgat, et al.
British Journal of Haematology|June 1, 2021
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment responseSebastiaan D T Sassen, Ron A A Mathôt, Rob Pieters, et al.
JCO Precision Oncology|June 21, 2023
Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?Annelienke M van Hulst, Martha A Grootenhuis, Emma J Verwaaijen, et al.
The Lancet. Haematology|December 4, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trialAndrea Biondi, Virginie Gandemer, Paola De Lorenzo, et al.
Pageof 34